Can we predict hidden polyps in kidney stone patients?
NCT ID NCT07559721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for factors that might predict inflammatory polyps in the ureter (the tube from kidney to bladder) in people with kidney stones. Researchers will review past patient data and then test their predictions on new patients. The goal is to create a simple tool that helps surgeons know what to expect before surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which kidney stone patients are likely to have inflammatory polyps, potentially improving surgical outcomes.
- What could go wrong
- This is an observational study, not a treatment trial. The model may not be accurate enough for widespread use, and results from one hospital may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 779 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2018
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population includes adult patients with ureteral calculi who underwent ureteroscopic treatment at the First Hospital of Jilin University. The retrospective cohort includes patients treated between 2018 and 2025, and the prospective cohort is recruiting new patients for validation.
- Ages
-
18 to 80 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or older undergoing ureteroscopic surgery for ureteral calculi at the First Hospital of Jilin University. * Complete clinical and imaging data available. Exclusion Criteria: * Patients with bilateral ureteral calculi. * Patients with preoperative nephrostomy or indwelling ureteral stent. * Patients with a history of ureteral or bladder cancer. * Patients with congenital ureteral anomalies or previous ureteral surgery. * Patients with severe coagulation disorders or contraindications to ureteroscopy. * Patients unable to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ureteral calculi are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shock waves vs. scope: a Head-to-Head battle for kidney stone relief
- World's largest kidney stone surgery study launches
- Can an amino acid help pass kidney stones better than a standard drug?
- Bladder drug may save kids from second surgery for kidney stones
- New stent aims to make kidney stone recovery less painful
- Sleep aid and bladder drug tested to ease stent discomfort